Vimarsana
Biggest News Aggregation in the World

Data Lock News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data Lock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Lock Today - Breaking & Trending Today

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights - Vimarsana News

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights

Published: March 28, 2024

/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announces...

Source: prnewswire.com
Related Topics:
United StatesStephen WillardTherapeutics IncNrx PharmaceuticalsUs National Institutes Of HealthUs Patient Centered Outcomes Research InitiativeAlvogen IncNephron PharmaceuticalsLotus Pharmaceuticals IncNrxp Nrx PharmaceuticalsPrnewswire Nrx Pharmaceuticals IncSpecialty Pharmaceutical CompanyCompany Board Of DirectorsLotus PharmaceuticalsSuicidal Bipolar DepressionData LockInvestigational New DrugChronic PainComplicated Urinary TractCentered Outcomes Research InitiativeElectroconvulsive TherapySevere DepressionNew Drug ApplicationAcute SuicidalityComplicated Urinary Tract Infection
NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights -March 28, 2024 at 08:04 am EDT - Vimarsana News

NRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights -March 28, 2024 at 08:04 am EDT

Published: March 28, 2024

Four potential near-term milestones, including data from two clinical trials, an NDA filing and a share dividend RADNOR, Pa., March 28, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. , a...

Source: marketscreener.com
Related Topics:
United StatesStephen WillardTherapeutics IncNrx PharmaceuticalsSource Nrx Pharmaceuticals IncSecurities ExchangeUs National Institutes Of HealthUs Patient Centered Outcomes Research InitiativeNephron PharmaceuticalsAlvogen IncExchange CommissionLotus Pharmaceuticals IncNrxp Nrx PharmaceuticalsPrnewswire Nrx Pharmaceuticals IncSpecialty Pharmaceutical CompanyCompany Board Of DirectorsLotus PharmaceuticalsSuicidal Bipolar DepressionData LockInvestigational New DrugChronic PainComplicated Urinary TractCentered Outcomes Research InitiativeElectroconvulsive TherapySevere Depression